Vanda Pharmaceuticals Inc. (VNDA) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2200 PENNSYLVANIA AVE NW WASHINGTON, DC 20037 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 135,821 | 135,029 | 432,813 | 367,740 | 312,129 | 257,360 | |||
| Cash and cash equivalent | 135,821 | 135,029 | 52,071 | 61,031 | 45,072 | 61,005 | |||
| Short-term investments | 380,742 | 306,709 | 267,057 | 196,355 | |||||
| Receivables | 34,155 | 33,512 | 32,467 | 30,036 | 26,367 | 28,780 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,357 | 1,194 | 1,025 | 1,280 | 1,140 | 994 | |||
| Inventory | 1,357 | 1,194 | 1,025 | 1,280 | 1,140 | 994 | |||
| Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss | ✕ | 252,520 | 333,368 | ✕ | ✕ | ✕ | |||
| Other undisclosed current assets | 9,093 | 16,189 | 11,996 | 10,089 | 14,500 | 11,998 | |||
| Total current assets: | 432,946 | 519,292 | 478,301 | 409,145 | 354,136 | 299,132 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 8,848 | 10,296 | 7,227 | 5,091 | 2,824 | 2,892 | |||
| Finance lease, right-of-use asset, after accumulated amortization | ✕ | ||||||||
| Operating lease, right-of-use asset | 7,103 | 8,400 | 9,272 | 10,459 | ✕ | ||||
| Property, plant and equipment | 2,037 | 2,573 | 3,113 | 4,136 | 3,864 | 4,417 | |||
| Intangible assets, net (including goodwill) | 121,369 | 18,565 | 20,081 | 21,559 | 23,037 | 24,542 | |||
| Intangible assets, net (excluding goodwill) | 121,369 | 18,565 | 20,081 | 21,559 | 23,037 | 24,542 | |||
| Deferred income tax assets | 75,000 | 74,039 | 74,878 | 81,516 | ✕ | ||||
| Other undisclosed noncurrent assets | 1,137 | 1,082 | 920 | 1,550 | 99,887 | 1,147 | |||
| Total noncurrent assets: | 215,494 | 114,955 | 115,491 | 124,311 | 129,612 | 32,998 | |||
| TOTAL ASSETS: | 648,440 | 634,247 | 593,792 | 533,456 | 483,748 | 332,130 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 38,460 | 45,551 | 34,438 | 31,509 | 27,590 | 21,584 | |||
| Employee-related liabilities | ✕ | ✕ | 6,839 | 6,515 | 10,951 | 6,597 | 6,363 | ||
| Accrued liabilities | 13,226 | 14,220 | 14,605 | 11,918 | 12,953 | 9,628 | |||
| Other undisclosed accounts payable and accrued liabilities | 25,234 | 24,492 | 13,318 | 8,640 | 8,040 | 5,593 | |||
| Other undisclosed current liabilities | 49,237 | 45,885 | 39,981 | 34,427 | 31,915 | 31,431 | |||
| Total current liabilities: | 87,697 | 91,436 | 74,419 | 65,936 | 59,505 | 53,015 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 10,055 | 11,497 | |||||||
| Finance lease, liability | ✕ | ||||||||
| Liabilities, other than long-term debt | 15,833 | 15,613 | 4,390 | 2,757 | 843 | 3,693 | |||
| Other liabilities | 8,827 | 6,800 | 4,390 | 2,757 | 843 | 3,693 | |||
| Operating lease, liability | 7,006 | 8,813 | 10,055 | 11,497 | ✕ | ||||
| Other undisclosed noncurrent liabilities | 12,455 | ||||||||
| Total noncurrent liabilities: | 15,833 | 15,613 | 14,445 | 14,254 | 13,298 | 3,693 | |||
| Total liabilities: | 103,530 | 107,049 | 88,864 | 80,190 | 72,803 | 56,708 | |||
| Equity | |||||||||
| Equity, attributable to parent | 544,910 | 527,198 | 504,928 | 453,266 | 410,945 | 275,422 | |||
| Common stock | 58 | 57 | 56 | 55 | 54 | 52 | |||
| Additional paid in capital | 700,274 | 686,235 | 669,223 | 650,300 | 631,307 | 611,587 | |||
| Accumulated other comprehensive income (loss) | (30) | (1,193) | (175) | 239 | 249 | 1 | |||
| Accumulated deficit | (155,392) | (157,901) | (164,176) | (197,328) | (220,665) | (336,218) | |||
| Total equity: | 544,910 | 527,198 | 504,928 | 453,266 | 410,945 | 275,422 | |||
| TOTAL LIABILITIES AND EQUITY: | 648,440 | 634,247 | 593,792 | 533,456 | 483,748 | 332,130 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 192,640 | 254,382 | 268,682 | 248,168 | 227,188 | 193,118 | ||
| Cost of revenue | (14,796) | (24,282) | (25,629) | (23,364) | (24,488) | (20,508) | ||
| Cost of product and service sold | (14,796) | (24,282) | (25,629) | (23,364) | ||||
| Gross profit: | 177,844 | 230,100 | 243,053 | 224,804 | 202,700 | 172,610 | ||
| Operating expenses | (191,796) | (223,771) | (200,888) | (197,565) | (179,890) | (150,872) | ||
| Operating income (loss): | (13,952) | 6,329 | 42,165 | 27,239 | 22,810 | 21,738 | ||
| Interest and debt expense | ||||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 4,416 | 6,218 | 3,608 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (13,952) | 6,329 | 42,165 | 31,655 | 29,028 | 25,346 | ||
| Other undisclosed income from continuing operations before income taxes | 20,291 | 4,971 | 199 | |||||
| Income (loss) from continuing operations before income taxes: | 6,339 | 11,300 | 42,364 | 31,655 | 29,028 | 25,346 | ||
| Income tax expense (benefit) | (3,830) | (5,025) | (9,212) | (8,318) | 86,525 | (138) | ||
| Income (loss) from continuing operations: | 2,509 | 6,275 | 33,152 | 23,337 | 115,553 | 25,208 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 33,152 | 23,337 | 115,553 | 25,208 | |
| Net income (loss) available to common stockholders, diluted: | 2,509 | 6,275 | 33,152 | 23,337 | 115,553 | 25,208 | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 2,509 | 6,275 | 33,152 | 23,337 | 115,553 | 25,208 | ||
| Other comprehensive income (loss) | 1,163 | (1,018) | (414) | (10) | 248 | 35 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 3,672 | 5,257 | 32,738 | 23,327 | 115,801 | 25,243 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.